APOB and chronic kidney disease: ApoB is increased at all stages of CKD, and as catabolism of very low-density lipid (VLDL)-ApoB-100 is slowed in CKD, accumulation of ApoB-containing lipoproteins may result primarily from decreased clearance rather than from increased synthesis [8–10].